|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0034656,
umls-concept:C0183683,
umls-concept:C0229601,
umls-concept:C0344211,
umls-concept:C0439859,
umls-concept:C0746319,
umls-concept:C1171411,
umls-concept:C1274040,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1516213,
umls-concept:C1521721,
umls-concept:C1707455
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-6-15
|
|
pubmed:abstractText |
Investigation of high-dose chemotherapy (HD-CT) followed by autologous hematopoietic stem-cell support compared with standard-dose chemotherapy (SD-CT) as adjuvant treatment in patients with primary breast cancer and 10 or more positive axillary lymph nodes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BerdelW EWE,
pubmed-author:CarstensenMM,
pubmed-author:FrickhofenNN,
pubmed-author:JänickeFF,
pubmed-author:JonasPP,
pubmed-author:KoenigsmannMM,
pubmed-author:KrögerNN,
pubmed-author:KrügerWW,
pubmed-author:KreienbergRR,
pubmed-author:MöbusVV,
pubmed-author:MetznerBB,
pubmed-author:PossingerKK,
pubmed-author:SchmidtE HEH,
pubmed-author:SchmoorCC,
pubmed-author:SchultzeWW,
pubmed-author:SchumacherMM,
pubmed-author:ThielEE,
pubmed-author:TrümperLL,
pubmed-author:WandtHH,
pubmed-author:ZanderA RAR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2273-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15111618-Adult,
pubmed-meshheading:15111618-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15111618-Breast Neoplasms,
pubmed-meshheading:15111618-Chemotherapy, Adjuvant,
pubmed-meshheading:15111618-Combined Modality Therapy,
pubmed-meshheading:15111618-Disease-Free Survival,
pubmed-meshheading:15111618-Female,
pubmed-meshheading:15111618-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:15111618-Humans,
pubmed-meshheading:15111618-Lymphatic Metastasis,
pubmed-meshheading:15111618-Middle Aged,
pubmed-meshheading:15111618-Prognosis,
pubmed-meshheading:15111618-Survival Analysis,
pubmed-meshheading:15111618-Transplantation, Autologous
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
|
|
pubmed:affiliation |
Transplant Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. zander@uke.uni-hamburg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
